Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report
Abstract Background Approximately 10% of all Graves' disease cases are triiodothyronine (T3)-predominant. T3-predominance is characterized by higher T3 levels than thyroxine (T4) levels. Thyroid stimulating hormone receptor autoantibody (TRAb) levels are higher in T3-predominant Graves' di...
Saved in:
Main Authors: | Akiko Fujishima (Author), Akira Sato (Author), Hiroshi Miura (Author), Yuki Shimoda (Author), Saeko Kameyama (Author), Chika Ariake (Author), Hiroyuki Adachi (Author), Yuki Fukuoka (Author), Yukihiro Terada (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic Systemic Effects Triiodothyronine
by: E. A. Troshina, et al.
Published: (2020) -
Triiodothyronine levels and mortality in children with sepsis and septic shock
by: Cynthea Prima Destariani, et al.
Published: (2018) -
Current knowledge about the in utero and peripartum management of fetal goiter associated with maternal Graves' disease
by: Shigeo Iijima
Published: (2019) -
Triiodothyronin (T3) as a parameter of mortality in sepsis patients in the PICU
by: Sri Wahyuni Djoko, et al.
Published: (2019) -
Triiodothyronine Attenuates Prostate Cancer Progression Mediated by β-Adrenergic Stimulation
by: Evangelina Delgado-González, et al.
Published: (2016)